FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma  Aleksandr Lazaryan, MD MPH PhD, Linda J. Burns, MD, Qing Cao, MS, Kaan Meric, MD, Claudio Brunstein, MD, PhD, Brian Lee McClune, DO, Mukta Arora, MD, MS, Margaret L. MacMillan, MD, MSc, Jerry Froelich, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Veronika Bachanova, MD  Biology of Blood and Marrow Transplantation  Volume 21, Issue 2, Pages S86-S87 (February 2015) DOI: 10.1016/j.bbmt.2014.11.104 Copyright © 2015 Terms and Conditions

Figure Overall survival and relapse risk according to pre-transplant FDG-PET status by Deauville criteria. Biology of Blood and Marrow Transplantation 2015 21, S86-S87DOI: (10.1016/j.bbmt.2014.11.104) Copyright © 2015 Terms and Conditions